519 related articles for article (PubMed ID: 26104579)
1. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
3. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
4. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.
Tam FW; Riser BL; Meeran K; Rambow J; Pusey CD; Frankel AH
Cytokine; 2009 Jul; 47(1):37-42. PubMed ID: 19409809
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
Shaker OG; Sadik NA
Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
[TBL] [Abstract][Full Text] [Related]
6. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
Satirapoj B; Dispan R; Radinahamed P; Kitiyakara C
BMC Nephrol; 2018 Sep; 19(1):246. PubMed ID: 30241508
[TBL] [Abstract][Full Text] [Related]
7. Correlation between urine vitamin D
Huang Y; Chen S; Dai Q; Zhang H; Liu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 48(1):40-48. PubMed ID: 36935176
[TBL] [Abstract][Full Text] [Related]
8. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
[TBL] [Abstract][Full Text] [Related]
9. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
10. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.
Fujita H; Morii T; Koshimura J; Ishikawa M; Kato M; Miura T; Sasaki H; Narita T; Ito S; Kakei M
Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829
[TBL] [Abstract][Full Text] [Related]
11. Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
Ibrahim S; Rashed L
Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):911-7. PubMed ID: 18974575
[TBL] [Abstract][Full Text] [Related]
12. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
[TBL] [Abstract][Full Text] [Related]
13. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.
Morii T; Fujita H; Narita T; Shimotomai T; Fujishima H; Yoshioka N; Imai H; Kakei M; Ito S
J Diabetes Complications; 2003; 17(1):11-5. PubMed ID: 12505750
[TBL] [Abstract][Full Text] [Related]
14. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Knowler WC; Rovin BH; Wu H; Klein JB; Mifflin TE; Feldman HI; Vasan RS; Kimmel PL; Kusek JW; Mauer M;
Nephrol Dial Transplant; 2015 Apr; 30(4):599-606. PubMed ID: 25648911
[TBL] [Abstract][Full Text] [Related]
15. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
Bessa SS; Hussein TA; Morad MA; Amer AM
Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
[TBL] [Abstract][Full Text] [Related]
16. Multiplex bead analysis of urinary cytokines of type 2 diabetic patients with normo- and microalbuminuria.
Liu J; Zhao Z; Willcox MD; Xu B; Shi B
J Immunoassay Immunochem; 2010; 31(4):279-89. PubMed ID: 21113841
[TBL] [Abstract][Full Text] [Related]
17. miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy.
Jia Y; Guan M; Zheng Z; Zhang Q; Tang C; Xu W; Xiao Z; Wang L; Xue Y
J Diabetes Res; 2016; 2016():7932765. PubMed ID: 26942205
[TBL] [Abstract][Full Text] [Related]
18. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Takebayashi K; Matsumoto S; Aso Y; Inukai T
J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
[TBL] [Abstract][Full Text] [Related]
19. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
20. Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy.
Titan SM; Vieira JM; Dominguez WV; Moreira SR; Pereira AB; Barros RT; Zatz R
J Diabetes Complications; 2012; 26(6):546-53. PubMed ID: 22981148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]